Literature DB >> 24980604

A meta-analysis of surgical versus nonsurgical management of recurrent thymoma.

Masatsugu Hamaji1, Syed Osman Ali2, Bryan M Burt3.   

Abstract

This meta-analysis was designed to determine the effect of surgical and nonsurgical approaches on 5-year and 10-year overall survival (OS) in patients with recurrent thymoma. PubMed, Scopus, and the Journal of Japanese Association for Chest Surgery were queried, and 11 studies were eligible. Our meta-analysis using a random-effect model revealed significant differences in the rates of 5- and 10-year OS after thymectomy and in 5-year OS after recurrence, favoring surgically managed patients. Surgical resection may be associated with improved long-term survival and should be considered for patients with recurrent thymoma.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24980604     DOI: 10.1016/j.athoracsur.2014.04.028

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  Video assisted thoracic surgery (VATS) for recurrent thymoma.

Authors:  Giuseppe Marulli; Giovanni Maria Comacchio; Federico Rea
Journal:  Ann Cardiothorac Surg       Date:  2015-11

2.  Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progression.

Authors:  Giuseppe L Banna; Ankur Sheel; Varun Sheel; Andrea Bille; Tom Routledge; Shalini Fernando; Arjun Nair; Rohit Lal
Journal:  Future Oncol       Date:  2017-11-10       Impact factor: 3.404

3.  Pleural recurrences of thymoma: role and effectiveness of intrathoracic chemohyperthermia.

Authors:  Giuseppe Marulli; Marco Mammana; Giovanni Maria Comacchio; Federico Rea
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

4.  Surgical treatment of single and multiple thymoma recurrences.

Authors:  Angelo Carretta; Paola Ciriaco; Piergiorgio Muriana; Alessandro Bandiera; Giampiero Negri
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-10-22

5.  T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis.

Authors:  Claudia Omarini; Federico Piacentini; Isabella Sperduti; Krisida Cerma; Monica Barbolini; Fabio Canino; Cecilia Nasso; Christel Isca; Federica Caggia; Massimo Dominici; Luca Moscetti
Journal:  BMC Cancer       Date:  2022-06-07       Impact factor: 4.638

Review 6.  The clinical features, diagnosis and management of recurrent thymoma.

Authors:  Taobo Luo; Hongguang Zhao; Xinming Zhou
Journal:  J Cardiothorac Surg       Date:  2016-08-31       Impact factor: 1.637

7.  Long-term outcomes of 307 patients after complete thymoma resection.

Authors:  Zu-Yang Yuan; Shu-Geng Gao; Ju-Wei Mu; Qi Xue; You-Sheng Mao; Da-Li Wang; Jun Zhao; Yu-Shun Gao; Jin-Feng Huang; Jie He
Journal:  Chin J Cancer       Date:  2017-05-15

8.  Thymoma Recurrence and its Predisposing Factors in Iranian Population: a Single Center Study.

Authors:  Sharareh Seifi; Babak Salimi; Adnan Khosravi; Zahra Esfahani-Monfared; Mihan Pourabdollah; Kambiz Sheikhi
Journal:  Tanaffos       Date:  2019-04

9.  Novel Treatments for Thymoma and Thymic Carcinoma.

Authors:  Arun Rajan; Heather Wakelee; Giuseppe Giaccone
Journal:  Front Oncol       Date:  2015-11-30       Impact factor: 6.244

10.  A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas.

Authors:  Milan Radovich; Jeffrey P Solzak; Bradley A Hancock; Madison L Conces; Rutuja Atale; Ryan F Porter; Jin Zhu; Jarret Glasscock; Kenneth A Kesler; Sunil S Badve; Bryan P Schneider; Patrick J Loehrer
Journal:  Br J Cancer       Date:  2016-01-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.